Research Study Summary
Patients are needed to participate in a clinical research study of caspofungin to evaluate Invasive Pulmonary Aspergillosis or Chronic Obstructive Pulmonary Disease
Research Study Title
Prospective, Open-label Study of the Efficacy and Safety of Caspofungin for the Treatment of Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease
The investigators propose to study the efficacy and safety of three-week antifungal therapy
with caspofungin in hospitalized patients with proven or probable IPA underlying chronic
obstructive pulmonary disease.
To Learn more